Littleton Regional Healthcare · Emergency Department
Pediatric Emergencies
BETA
Not yet ready for clinical use. Shared for feedback and practice only — do not use it to direct the care of a patient.
Content is unverified and unapproved. Every situation requires nuance; use your professional judgment and your department's policies. Weight-based doses are calculated live from the weight you enter — double-check every calculated dose yourself before giving it.
NEWLY BORN (first days of life)? Use NEONATAL RESUSCITATION (NRP) → — doses differ: epi 0.02 mg/kg (NRP) vs 0.01 mg/kg (PALS). Older infant who simply weighs <3 kg? Dismiss and continue with PALS.
CASE TIMELINE
Times and events only — no patient identifiers, no weight value. Not a medical record. Clears on RESET.
Littleton Regional Healthcare · Emergency Department
Pediatric Emergencies
Enter a weight once above — every card below calculates its doses live from it. Weight and timers live only on this device, clear on RESET FOR NEXT CASE, and auto-clear after an hour of inactivity — still, always tap RESET between patients.
IM epinephrine immediately — everything else is an adjunct. Watch the airway if there's angioedema/stridor.
EPINEPHRINE — CALCULATED FROM WEIGHT ABOVE
Route
Dose
Max
Repeat
IM (1:1000), anterolateral thigh
0.01 mg/kg = enter weight above
0.5 mg (WAO 2020)
q5–15min
SINCE LAST EPI DOSE
—
Tap each button when that dose is given — each is time-stamped to the case timeline.
IV BOLUS DOSE1 mcg/kg = enter weight abovemax 50 mcg
The 2023 AAAAI/ACAAI update caps the pediatric/teen dose at 0.3 mg instead of 0.5 mg — the two major sources disagree on the ceiling; this tool uses the WAO 2020 figure (0.5 mg) but confirm which cap your pharmacy/EMS protocol uses. Auto-injector fixed doses (for reference, not a substitute for a weight-based calculation when you can draw one up): 0.1 mg for 7.5–15 kg, 0.15 mg for 15–30 kg, 0.3 mg for ≥30 kg — some bodies now favor switching to the 0.3 mg device closer to 25 kg to avoid underdosing.
IF NOT RESPONDING TO IM EPI
ADJUNCTS — CALCULATED FROM WEIGHT ABOVE — NOT FIRST-LINE, DON'T DELAY EPI FOR THESE
These relieve itch/hives (antihistamine), blunt a biphasic reaction (steroid), or treat bronchospasm/stridor (albuterol, racemic epi) — none replace IM epinephrine for the airway/hemodynamic compromise. Doses per the originating hospital's Pediatric General PowerPlan (Cerner order set) where marked; otherwise institutional pediatric ED pathways.
Observation after treatment: a large 2025 pediatric ED cohort (5,641 patients, 31 sites) found only 4.7% needed repeat epinephrine after 2 hours and 1.9% after 4 hours — suggesting 2 hours is likely sufficient for children without cardiovascular involvement, 4 hours for those with cardiovascular symptoms. Older institutional pathways still specify a flat 4–6 hour observation; a small rural ED without close follow-up access may reasonably choose the more conservative standard.
Sources: World Allergy Organization Anaphylaxis Guidance 2020 (epinephrine 0.01 mg/kg IM, max 0.5 mg, repeat q5–15min; 20 mL/kg fluid bolus); AAAAI/ACAAI Anaphylaxis: A 2023 Practice Parameter Update (0.3 mg pediatric epinephrine cap — conflicts with WAO's 0.5 mg, noted above); Johns Hopkins All Children's Hospital Anaphylaxis Clinical Pathway 2023 (adjunct dosing); Dribin TE, et al., "Timing of repeat epinephrine to inform paediatric anaphylaxis observation periods," Lancet Child Adolesc Health 2025;9(7):484-496. The originating hospital's Pediatric General PowerPlan (Cerner order set) — dexamethasone 0.6 mg/kg (max 10 mg), albuterol nebulizer q20min ×3, racemic epinephrine 2.25% 0.5 mL neb (0.25 mL if <5 kg, dilute in 3 mL NS), and the epinephrine IM 0.01 mg/kg <15 kg / EpiPen Jr 15–29.9 kg / EpiPen ≥30 kg tiering. IV-epinephrine bolus/infusion figures are standard pediatric-resuscitation references, not PowerPlan values — confirm with pharmacy.
— personal/unofficial aid, not part of the hospital IT system/EHR, not a substitute for clinical judgment. Verify all values locally.
03Asthma Exacerbation
DEXAMETHASONE-FIRST · PASS SEVERITY
NAME
"Pediatric asthma exacerbation — [mild/moderate/severe], starting weight-based albuterol." Say it out loud.
CLAIM
Nebulizer/MDI setup · dexamethasone · IV access if severe · monitoring — assign aloud.
AIM
Determine PASS severity first — it decides everything downstream. Dexamethasone up front, weight-based albuterol, escalate fast if severe.
ESCALATION MEDICATIONS — CALCULATED FROM WEIGHT ABOVE
Sources: Children's Hospital of Philadelphia, Emergency Department Clinical Pathway for Evaluation/Treatment of Children with Asthma, last revised May 2026 — PASS severity triage, weight-tiered albuterol/ipratropium dosing, dexamethasone weight-band dosing, magnesium/terbutaline escalation dosing, and the overall dexamethasone-first pathway structure. The originating hospital's Pediatric General PowerPlan (Cerner order set) — albuterol nebulizer/DuoNeb q20min ×3, albuterol HFA 4 puffs, dexamethasone 0.6 mg/kg (max 10 mg) and prednisolone 2 mg/kg (max 60 mg) as the originating hospital's ordered equivalents of the CHOP weight bands.
— personal/unofficial aid, not part of the hospital IT system/EHR, not a substitute for clinical judgment. Verify all values locally.
04Airway Obstruction (Choking)
FOREIGN BODY ASPIRATION
NAME
"Choking — complete/partial obstruction, [age]." Say it out loud.
Sources: AHA/AAP 2025 Guidelines for CPR and ECC, Part 6: Pediatric BLS, Circulation 2025 (CIR.0000000000001370) — back-blow/thrust technique by age, contraindication of abdominal thrusts in infants; American Red Cross FBAO Guidelines Database. StatPearls, Foreign Body Airway Obstruction and Cricothyroidotomy; WikEM and LITFL, needle cricothyrotomy age/size discussion — presented as an area of genuine guideline disagreement, not a fixed cutoff.
— personal/unofficial aid, not part of the hospital IT system/EHR, not a substitute for clinical judgment. Verify all values locally.
05Epiglottitis / Upper Airway Emergency
DO NOT AGITATE · DO NOT EXAMINE THE AIRWAY
NAME
"Possible epiglottitis — keeping the child calm with the parent, calling for airway backup now." Say it out loud.
CLAIM
Minimal-handling protocol · blow-by O₂ · transfer team call · surgical airway kit at bedside — assign aloud.
AIM
Disturb the least, prepare for the worst. Don't touch the airway or agitate the child — call for transport and an airway team in parallel.
Do not lay the child flat. Do not place an IV. Do not examine the oropharynx with a tongue depressor. Do not force a mask onto the face. Any of these can precipitate sudden complete obstruction via a ball-valve effect.
CLASSIC PRESENTATION
RURAL ED — WHAT TO DO WHILE AWAITING TRANSFER
MEDICAL ADJUNCTS — ONLY IF GIVABLE WITHOUT AGITATING THE CHILD
ANTIBIOTICS ONCE AIRWAY IS SECURED
CROUP vs. EPIGLOTTITIS vs. BACTERIAL TRACHEITIS
Croup
Epiglottitis
Bacterial tracheitis
Age
6mo–3y
2–7y (shifting older)
6mo–14y
Cause
Viral
Bacterial
Bacterial (post-viral)
Onset
Gradual
Very rapid (hours)
Rapid
Cough
Barking
Suppressed/absent
Present, brassy
Drooling
No
Yes
No
Position
Comfortable supine
Tripod, neck extended
Can lie supine, toxic
Imaging
Steeple sign (AP)
Thumbprint sign (lateral)
Steeple + irregular tracheal air
Imaging should never delay airway management or be attempted in an unstable, tripoding, drooling child — clinical gestalt overrides radiographic confirmation.
Sources: StatPearls, Epiglottitis (NBK430960); WikEM, "Epiglottitis" and antibiotic dosing template; EMCrit IBCC, "Epiglottitis" (Farkas); RCEMLearning, croup/epiglottitis/tracheitis comparison. Post-Hib epidemiology per PubMed 23076559 and PMC2870429. No rural-specific stabilize-and-transfer guideline exists for this condition — that section is a synthesis of general principles, not a direct quote from a named protocol. Racemic epinephrine and dexamethasone doses per the originating hospital's Pediatric General PowerPlan (Cerner order set); their use in epiglottitis specifically is temporizing/low-evidence — the do-not-agitate principle overrides both.
— personal/unofficial aid, not part of the hospital IT system/EHR, not a substitute for clinical judgment. Verify all values locally.
06Bronchiolitis
SUPPORTIVE CARE — NOT ASTHMA, DON'T TREAT IT LIKE ASTHMA
NAME
"Bronchiolitis — supportive care, watching for respiratory failure." Say it out loud.
Supportive care is the treatment — bronchodilators/epi/steroids don't work here. Watch closely for apnea/respiratory failure, especially in young infants.
Bronchiolitis is a clinical diagnosis in a typical presentation (viral prodrome, then increased work of breathing with crackles/wheeze in an infant <24 months) — routine labs and chest imaging are not needed in a straightforward case and mainly add noise/false reassurance.
SUPPORTIVE CARE (what actually works)
WHAT DOESN'T WORK — DON'T TREAT THIS LIKE ASTHMA
WATCH FOR RESPIRATORY FAILURE
Sources: Friedman JN, Rieder MJ, Walton JM; Canadian Paediatric Society, Bronchiolitis: Recommendations for diagnosis, monitoring and management of children one to 24 months of age, 2021 (cps.ca/en/documents/position/bronchiolitis) — supportive-care-only framework, discouraging bronchodilators/steroids/chest physio/routine hypertonic saline, and the SpO₂ target discussion. Bronchiolitis-vs-asthma distinction and apnea/respiratory-failure progression pattern cross-checked against a University of British Columbia Department of Emergency Medicine simulation case (Salehmohamed, 2022), used here only as a teaching-scenario cross-check, not as an independent clinical source.
— personal/unofficial aid, not part of the hospital IT system/EHR, not a substitute for clinical judgment. Verify all values locally.
07Diabetic Ketoacidosis (DKA)
SLOW, STEADY CORRECTION · WATCH FOR CEREBRAL EDEMA
NAME
"Suspected pediatric DKA — starting fluids, watching for cerebral edema." Say it out loud.
Rehydrate first, start insulin only after the first bolus, correct slowly (50–100 mg/dL/hr glucose drop), and watch for cerebral edema the whole time.
Cerebral edema occurs in 0.3–0.9% of pediatric DKA with 21–24% mortality, and can appear before, during, or after treatment (typically within 12h). Watch for new headache, recurrent vomiting, altered mental status, urinary incontinence, or a Cushing triad (bradycardia, irregular respirations, hypertension) — treat empirically on high suspicion, don't wait for imaging.
DIAGNOSIS & INITIAL ASSESSMENT
FLUIDS — CALCULATED FROM WEIGHT ABOVE
2-BAG DEXTROSE SYSTEM (by blood glucose)
Blood glucose
Dextrose in IVF
<200 mg/dL
All D10 0.9% NaCl
200–299 mg/dL
Half D10 0.9% NaCl, half 0.9% NaCl
≥300 mg/dL
All 0.9% NaCl
If glucose is needed before electrolyte results are back, use D10 0.45% NaCl. Rate: 1.5× maintenance. Goal glucose drop: 50–100 mg/dL/hr — adjust the dextrose concentration to hit this, don't just stop insulin to slow the drop.
POTASSIUM REPLACEMENT (by serum K⁺)
Serum K⁺
KCl in IVF
KPhos in IVF
<4 mEq/L
30 mEq
30 mEq (20.4 mM)
4–5.4 mEq/L
20 mEq
20 mEq (13.6 mM)
5.5–6 mEq/L
10 mEq
10 mEq (6.8 mM)
>6 mEq/L
None
None
Get an ECG if K⁺ <2.5 or >6 mEq/L. Sodium bicarbonate is not recommended for DKA acidosis correction.
INSULIN & MONITORING
SMALL RURAL ED — ICU ADMISSION / TRANSFER
Sources: Children's Hospital of Philadelphia, Emergency Department, ICU and Inpatient Clinical Pathway for Evaluation/Treatment of Children with Suspected Diabetic Ketoacidosis (DKA), last revised May 2026 — diagnostic criteria, fluid bolus/2-bag dextrose system, potassium replacement table, insulin timing/infusion rate, monitoring cadence, and resolution/transition criteria. ISPAD Clinical Practice Consensus Guidelines 2022: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State (cerebral edema epidemiology/warning signs, cited within the CHOP pathway's own evidence page).
— personal/unofficial aid, not part of the hospital IT system/EHR, not a substitute for clinical judgment. Verify all values locally.
08Altered Mental Status
GLUCOSE FIRST · DON'T MISS THE RED FLAGS
NAME
"Altered mental status — checking glucose first." Say it out loud.
Airway/breathing/circulation, then glucose immediately. Work the differential fast — several causes (hypoglycemia, meningitis, abusive head trauma) are time-critical.
INITIAL STABILIZATION
DEXTROSE DOSING — CALCULATED FROM WEIGHT ABOVE ("5/2/1–50" rule)
Concentration
Dose
Calculated
D10W
5 mL/kg
enter weight above
D25W
2 mL/kg
enter weight above
D50W
1 mL/kg
enter weight above
Each row delivers the same "glucose dose" regardless of which concentration is on hand (5×10 = 2×25 = 1×50). D10/D25 preferred over D50 peripherally in children — extravasation/phlebitis risk. This is a widely-used educational convention, not a numbered society-guideline value — sensible but not independently graded evidence.
NALOXONE IF OPIOID EXPOSURE SUSPECTED
RED FLAGS TO RULE OUT FAST
The mnemonic AEIOU-TIPS (alcohol/acidosis, epilepsy/electrolytes, insulin, overdose, uremia, trauma, infection, psychiatric/poisoning, stroke/shock/seizure) is widely taught for organizing this differential — it's an educational convention, not an issued guideline.
Sources: Song JL, Wang VJ, "Altered Level of Consciousness in the Pediatric Patient," Pediatric Emergency Medicine Practice, EB Medicine, Jan 2017 (AEIOU-TIPS, GCS≤8 intubation threshold, initial-stabilization sequence); PEMBlog, "5/2/1–50" dextrose rule; AAP Technical Report, "Abusive Head Trauma in Infants and Children," Pediatrics 2025;155(3):e2024070457; ISPAD 2018 DKA/cerebral-edema criteria; Drugs.com pediatric naloxone dosing, cross-checked against the 1990 AAP addendum on naloxone dosing (conflict noted above — verify against a current pharmacy reference before printing a fixed number).
— personal/unofficial aid, not part of the hospital IT system/EHR, not a substitute for clinical judgment. Verify all values locally.
09Behavioral Agitation
DE-ESCALATE FIRST · MEDS ARE THE FALLBACK, NOT THE FIRST MOVE
NAME
"Acute agitation — de-escalating first, low-stimulation space." Say it out loud.
CLAIM
Verbal de-escalation lead · environment/family liaison · medication if needed · safety/monitoring — assign aloud.
AIM
Non-pharmacologic de-escalation is first-line, attempted before, during, and after any medication — never simply replaced by it. Restraint is a last resort.
DE-ESCALATION FIRST
IF MEDICATION IS NEEDED — ORAL BEFORE IM WHEN SAFE
Exact mg dosing varies across secondary institutional guidelines even when all cite the same consensus statement — treat these as expert-opinion-based, not RCT-derived, and confirm against your pharmacy's approved pediatric reference before printing a fixed number.
PHYSICAL RESTRAINT — LAST RESORT, AGE-BASED TIME LIMITS
Sources: Gerson R, et al., "Best Practices for Evaluation and Treatment of Agitated Children and Adolescents (BETA) in the Emergency Department," American Association for Emergency Psychiatry consensus statement, West J Emerg Med 2019; Foster AA, et al., "Standardizing and Improving Care for Pediatric Agitation Management in the Emergency Department," Pediatrics 2023;152(1):e2022059586 — de-escalation framework, medication choices/cautions, and restraint principles. Weight/age-banded dosing cross-checked against Children's Minnesota and Children's Hospital of Richmond institutional pediatric agitation guidelines. The originating hospital's Pediatric General PowerPlan (Cerner order set) — lorazepam 0.05 mg/kg PO (max 2 mg; avoid in autism spectrum disorder), olanzapine 2.5 mg (<30 kg)/5 mg (≥30 kg) PO, midazolam 0.3 mg/kg IN, droperidol or haloperidol 0.05 mg/kg IM (max 5 mg; continuous EKG/SpO₂ after), diphenhydramine 1 mg/kg IV (max 50 mg) PRN dystonia. Restraint time limits per 42 CFR §482.13, CMS Hospital Conditions of Participation.
— personal/unofficial aid, not part of the hospital IT system/EHR, not a substitute for clinical judgment. Verify all values locally.
10Status Epilepticus
CHILDREN >1 MONTH · MAX 2 BENZO DOSES
NAME
"Pediatric status epilepticus — starting the clock, benzo now." Say it out loud.
Benzodiazepine as early as possible — before you even check glucose. Never give more than 2 benzo doses; move to a second-line agent instead.
0:00
Tap START at seizure onset (>5 min continuous, or 2+ seizures without full recovery of consciousness = status epilepticus).
0–5 min STABILIZE
5–15 min BENZO ×2 MAX
15+ min 2ND-LINE
0–5 MIN — INITIAL MANAGEMENT
FIRST-LINE (BENZODIAZEPINE) — CALCULATED FROM WEIGHT ABOVE — MAX 2 DOSES TOTAL
Route
Weight tier
Dose
Max
Midazolam IM/IN (no IV/IO)
≤13 kg
0.2 mg/kg = enter weight above
10 mg
13–40 kg
5 mg fixed dose
10 mg
>40 kg
10 mg fixed dose
10 mg
Lorazepam IV/IO
—
0.1 mg/kg = enter weight above
4 mg
Midazolam IV/IO
—
0.1 mg/kg = enter weight above
10 mg
Prehospital: midazolam IM/IN per the weight tiers above; check glucose; if still seizing after 5 min, give a second midazolam dose (max cumulative 10 mg prehospital). ED: give a benzodiazepine if two doses haven't already been given prehospital; check glucose if not done; give a second dose 5 min after the first if still seizing, switching to IV/IO route once access is available. CAUTION: do not give more than 2 doses of benzodiazepines total.
SECOND-LINE (if still seizing after 2 benzo doses) — CALCULATED FROM WEIGHT ABOVE
Drug
Dose
Age
Key caution
Levetiracetam IV/IO (5 min infusion)
60 mg/kg = enter weight above (max 3000 mg)
Any age
↓ side effects/interactions, low psychosis risk
Fosphenytoin IV/IO/IM (10 min infusion)
20 mg PE/kg = enter weight above (max 1000 mg PE)
Any age, less common <6mo
↓BP, ↓HR, arrhythmia; avoid in toxicologic seizures
Same as fosphenytoin; use only if fosphenytoin unavailable
Phenobarbital IV/IO (20 min infusion)
20 mg/kg = enter weight above (max 1000 mg)
<6 months
Respiratory depression, especially with benzodiazepines
If still seizing after the first second-line agent, reassess ABCs and give an alternative second-line agent (e.g., if fosphenytoin was given, switch to levetiracetam) — don't just repeat the same drug.
PEDIATRIC REFERRAL CENTER DISCUSSION — if still seizing
Sources: EIIC (EMSC Innovation and Improvement Center), Pediatric Status Epilepticus Algorithm, Version 5.0, published August 2025 (original material developed by TREKK, modified by EIIC) — full timed algorithm, weight-tiered dosing, max-2-benzodiazepine-doses caution, second-line agent table, and pediatric-referral-center discussion points. For children over 1 month of age.
— personal/unofficial aid, not part of the hospital IT system/EHR, not a substitute for clinical judgment. Verify all values locally.
11Neonatal / Young Infant Fever
≥38.0°C · TERM, WELL-APPEARING, 8–60 DAYS
NAME
"Febrile infant, [X] days old — starting the age-based workup." Say it out loud.
CLAIM
Cultures/UA · empiric antibiotics if indicated · transfer coordination · recorder — assign aloud.
AIM
Age band decides the workup. Any infant <8 days or ill-appearing at any age gets the full workup regardless of these bands.
This card covers well-appearing, term (≥37 weeks) infants 8–60 days old with fever ≥38.0°C (100.4°F) and no focal source. Infants <8 days old, and any ill-appearing infant of any age, are outside this pathway — treat as high-risk: full workup, empiric antibiotics, admit.
WORKUP BY AGE BAND
Age
Workup
Disposition
8–21 days
Blood culture, UA+urine culture, and LP — full workup mandatory for all
Admit — mandatory for this entire band, regardless of results
22–28 days
Blood culture, UA+culture, inflammatory markers (ANC, CRP, procalcitonin) always. LP depends on marker/UA results — can be deferred only if all markers negative and follow-up (~24h) is assured.
If LP deferred: one dose empiric parenteral antibiotic + admit, or shared-decision discharge with close follow-up
29–60 days
Blood culture, UA, inflammatory markers. LP is selective — reserved for abnormal markers or positive UA in some pathways.
If UA and all markers negative → may forgo LP/antibiotics with close (24–36h) follow-up
Sources: Pantell RH, et al., "Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old," AAP Clinical Practice Guideline, Pediatrics 2021;148(2):e2021052228 — age bands, workup requirements, inflammatory-marker thresholds, and the "treat as CSF-positive if LP unobtainable" principle. Kuppermann N, et al. (PECARN Febrile Infant Rule), 2019, for reference on the 29–60/61–90 day rules outside this guideline's scope. Neonatal antibiotic dosing per standard neonatal formulary references (e.g. UW NICU dosing guide) — gentamicin dosing intentionally not reduced to a single number here; confirm with pharmacy/NICU. The originating hospital's ED Infant Care <90 Days PowerPlan (Cerner order set) — ampicillin 100 mg/kg + gentamicin 4 mg/kg IV (0–28 d; + acyclovir 20 mg/kg if HSV risk), ceftriaxone 50 mg/kg IV (non-meningitis) or 100 mg/kg + vancomycin 20 mg/kg (meningitis dosing), PECARN-based 29–60 d low-risk pathway (negative UA, ANC <4000, procalcitonin ≤0.5 ng/mL), acetaminophen IV 12.5 mg/kg (<29 d) / 15 mg/kg (≥29 d), D10W 2 mL/kg for hypoglycemia, NS 10–20 mL/kg boluses.
— personal/unofficial aid, not part of the hospital IT system/EHR, not a substitute for clinical judgment. Verify all values locally.
12Non-Accidental Trauma
SUSPECTED CHILD PHYSICAL ABUSE
NAME
"This injury pattern is concerning for abuse — starting the standard workup and involving social work." Say it out loud.
CLAIM
Exam/documentation · imaging orders · social work/CPS liaison · law enforcement if indicated — assign aloud.
AIM
"Those who don't cruise rarely bruise." Any bruising/injury in a non-mobile infant deserves a full workup, not reassurance — document objectively, report, and let a comprehensive workup rule things in or out.
RED FLAGS — TEN-4-FACESp (children <4 years)
STANDARD WORKUP WHEN NAT IS SUSPECTED
REPORTING & DOCUMENTATION
Sources: Pierce MC, et al., TEN-4-FACESp clinical decision rule (Lurie Children's Hospital/TRICAM), validated age <4 years. Sheets LK, et al., "Sentinel Injuries in Infants Evaluated for Child Physical Abuse," Pediatrics 2013;131(4):701-707. AAP Clinical Report, "Evaluating Young Children With Fractures for Child Abuse," Pediatrics 2025;155(2):e2024070074 (skeletal survey). AAP Technical Report, "Abusive Head Trauma in Infants and Children," Pediatrics 2025;155(3):e2024070457 (head imaging). American Academy of Ophthalmology/AAPOS Clinical Statement, "The Eye Examination in the Evaluation of Child Abuse" (2018, verify current version). AAP Clinical Reports, "Evaluation for Bleeding Disorders in Suspected Child Abuse" and companion report, Pediatrics 2022;150(4):e2022059276/77. NH RSA 169-C:29-31 (verify current text locally). No single validated NAT-specific imaging decision rule exists analogous to PECARN — the imaging-overlay section above synthesizes institutional consensus protocols (UCSF Benioff, Mary Bridge, Nationwide Children's), not one named guideline.
— personal/unofficial aid, not part of the hospital IT system/EHR, not a substitute for clinical judgment. Verify all values locally.
13Death of a Child in the ED
NOTIFICATION · FAMILY PRESENCE · LOGISTICS
NAME
"We need to notify the family — gathering the team and chaplaincy first." Say it out loud.
CLAIM
Family notification lead · chaplaincy/social work · ME/OPO notification · staff debrief coordination — assign aloud.
AIM
Use the word "died," not "passed" or "didn't make it." Notify the medical examiner and organ-procurement organization for every death — these are not optional or family-permission-gated.
FAMILY NOTIFICATION — GRIEV_ING
FAMILY PRESENCE DURING RESUSCITATION
TERMINATION OF RESUSCITATION — NO FIXED PEDIATRIC RULE
POST-DEATH LOGISTICS CHECKLIST
Sources: Hobgood C, et al., "The Educational Intervention 'GRIEV_ING' Improves the Death Notification Skills of Residents," Acad Emerg Med 2005;12(4):296-301. Emergency Nurses Association, Family Presence During Resuscitation and Invasive Procedures Clinical Practice Guideline (2019, synopsis 2024); Society of Trauma Nurses, position statement on family presence during pediatric trauma resuscitation, 2022. AAP/ACEP, "Death of a Child in the Emergency Department," Pediatrics 2014;134(1):e313 (pull full text locally — access-restricted during this research pass). AAP/ACEP/NAEMSP joint policy, "Withholding or Termination of Resuscitation in Pediatric Out-of-Hospital Traumatic Cardiopulmonary Arrest," Pediatrics 2014;133(4):e1104. 42 CFR §482.45(a)(1), CMS Hospital Conditions of Participation (OPO notification). NH RSA 611-B (verify locally). "Unexplained Pediatric Deaths," Academic Forensic Pathology International, 2019 (evidence preservation).
— personal/unofficial aid, not part of the hospital IT system/EHR, not a substitute for clinical judgment. Verify all values locally.
14Procedural Sedation
NPO STATUS NO LONGER GATES SEDATION
NAME
"Procedural sedation for [procedure] — monitoring and airway equipment ready first." Say it out loud.
CLAIM
Proceduralist · dedicated monitoring person (no other duties) · airway/rescue equipment ready — assign aloud.
AIM
Two-person minimum — one proceduralist, one monitoring only. Fasting time doesn't need to delay you; monitoring and a rescue plan do the safety work.
PRE-SEDATION — MONITORING & PERSONNEL, NOT A FASTING CLOCK
0.025–0.1 mg/kg (max 6 mg <6y, 10 mg ≥6y) = up to enter weight above
1–5 min / 0.5–2 hr
Intranasal midazolam (imaging)
~0.3 mg/kg = enter weight above (max 10 mg)
7–10 min
By procedure: fracture/dislocation reduction → IV ketamine alone, ketamine+propofol ("ketofol"), or propofol+fentanyl. Laceration repair → local/topical anesthesia first, then nitrous oxide ± oral/intranasal midazolam for anxiety. Non-painful imaging → intranasal midazolam first-line. Ketamine is relatively contraindicated under 3 months (higher laryngospasm risk); it preserves airway reflexes and is favored if unfasted or in reactive airway disease, and does not raise ICP.
COMPLICATIONS
RECOVERY / DISCHARGE CRITERIA
Sources: American College of Emergency Physicians, Clinical Policy: Procedural Sedation and Analgesia in the Emergency Department, Ann Emerg Med 2014;63(2):247-258 (current standing ACEP policy — NPO-status finding). Bhatt M, et al., "Unscheduled Procedural Sedation: A Multidisciplinary Consensus Practice Guideline" (11-society consensus incl. Society for Pediatric Sedation), Ann Emerg Med 2019;73(5):e51-e65. Coté CJ, Wilson S; AAP/AAPD, "Guidelines for Monitoring and Management of Pediatric Patients Before, During, and After Sedation," Pediatrics 2019;143(6):e20191000 (2016 update, reaffirmed 2025). StatPearls, Pediatric Procedural Sedation (NBK572100). Sherwin TS, et al., ketamine/midazolam emergence-reaction trial, Ann Emerg Med 2000. The originating hospital's Pediatric General PowerPlan (Cerner order set) — ketamine 2 mg/kg IV (max 100 mg) / 4 mg/kg IM (max 200 mg) initial procedural-sedation dosing, ondansetron 0.15 mg/kg IV 20 min pre-ketamine, midazolam 0.3 mg/kg IN (max 10 mg) / 0.5 mg/kg PO (max 20 mg) anxiolysis.
— personal/unofficial aid, not part of the hospital IT system/EHR, not a substitute for clinical judgment. Verify all values locally.
15Croup
DEX FOR ALL · RACEMIC EPI IF STRIDOR AT REST
NAME
"This looks like croup — barky cough, [no] stridor at rest." Say it out loud.
CLAIM
Dexamethasone · nebulizer setup if stridor at rest · keep child calm with parent — assign aloud.
AIM
Dexamethasone for every croup. Stridor at rest → racemic epi and observe 3–4 h after the last neb. Agitation worsens everything.
SEVERITY & TREATMENT — CALCULATED FROM WEIGHT ABOVE
DISPOSITION
Sources: The originating hospital's Pediatric General PowerPlan (Cerner order set) — dexamethasone 0.6 mg/kg PO/IV/IM max 10 mg (0.3 mg/kg PO listed as an alternative), racemic epinephrine 2.25% 0.5 mL nebulized (0.25 mL if <5 kg, dilute in 3 mL NS). General croup framework (dex-for-all, racemic epi for stridor at rest, 3–4 h post-epi observation, night-2–3 natural history) per standard pediatric EM references (WikEM/StatPearls croup; Bjornson & Johnson, Lancet croup reviews). Westley score intentionally omitted — severity here is the practical stridor-at-rest split, not a formal score.
— personal/unofficial aid, not part of the hospital IT system/EHR, not a substitute for clinical judgment. Verify all values locally.
16Airway Equipment Sizes
ETT · BLADE · SUPRAGLOTTIC · SUCTION
SIZES FOR THIS PATIENT — FROM THE WEIGHT ABOVE
FULL LADDER — EVERY CART DRAWER
BEFORE AND AFTER THE TUBE
Sources: AHA 2020 Guidelines, Part 4: Pediatric Basic and Advanced Life Support (Topjian et al., Circulation 2020;142:S469–S523; carried forward in the 2025 update) — cuffed tubes preferred at every age, cuffed size age/4 + 3.5 (Khine formula), uncuffed age/4 + 4, depth ≈ 3 × tube ID, capnography confirmation, DOPE. Suction catheter 2 × tube ID (Fr) and supraglottic weight ranges per standard airway references (Walls, Manual of Emergency Airway Management; manufacturer sizing). Color zones are the Broselow-Luten system (band boundaries per WikEM, as elsewhere on this page) — wayfinding to the cart drawer only; every displayed size comes from this page's own config, and the drawer's packed contents win over any formula. Verify against the tape at the bedside.
— personal/unofficial aid, not part of the hospital IT system/EHR, not a substitute for clinical judgment. Verify all values locally.